These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 30941232
1. Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer. Jeong H, Hwang I, Kang SH, Shin HC, Kwon SY. J Breast Cancer; 2019 Mar; 22(1):38-51. PubMed ID: 30941232 [Abstract] [Full Text] [Related]
2. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. Medrek C, Pontén F, Jirström K, Leandersson K. BMC Cancer; 2012 Jul 23; 12():306. PubMed ID: 22824040 [Abstract] [Full Text] [Related]
5. Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma. Yang M, Li Z, Ren M, Li S, Zhang L, Zhang X, Liu F. J Cancer; 2018 Jul 23; 9(13):2308-2316. PubMed ID: 30026826 [Abstract] [Full Text] [Related]
6. The relationship of tumour-associated macrophages (CD68, CD163, CD11c) and cancer stem cell (CD44) markers with prognostic parameters in breast carcinomas. Sari S, Özdemir Ç, Çilekar M. Pol J Pathol; 2022 Jul 23; 73(4):299-309. PubMed ID: 36946266 [Abstract] [Full Text] [Related]
7. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front. Wang X, Yuwen TJ, Zhong Y, Li ZG, Wang XY. Heliyon; 2023 Feb 23; 9(2):e13211. PubMed ID: 36798759 [Abstract] [Full Text] [Related]
9. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis. Allison E, Edirimanne S, Matthews J, Fuller SJ. Oncol Ther; 2023 Mar 23; 11(1):27-48. PubMed ID: 36484945 [Abstract] [Full Text] [Related]
10. Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients. Yi B, Cheng Y, Chang R, Zhou W, Tang H, Gao Y, Zhang C. Biosci Rep; 2023 Feb 27; 43(2):. PubMed ID: 36633963 [Abstract] [Full Text] [Related]
13. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V, Villarroel-Espindola F, Schalper KA, Pusztai L, Rimm DL. Breast Cancer Res; 2018 Dec 17; 20(1):154. PubMed ID: 30558648 [Abstract] [Full Text] [Related]
16. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma. Kim KJ, Wen XY, Yang HK, Kim WH, Kang GH. PLoS One; 2015 Dec 17; 10(12):e0144192. PubMed ID: 26714314 [Abstract] [Full Text] [Related]
19. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Salmi S, Siiskonen H, Sironen R, Tyynelä-Korhonen K, Hirschovits-Gerz B, Valkonen M, Auvinen P, Pasonen-Seppänen S. Melanoma Res; 2019 Jun 17; 29(3):237-247. PubMed ID: 30399061 [Abstract] [Full Text] [Related]
20. Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis. Zwager MC, Bense R, Waaijer S, Qiu SQ, Timmer-Bosscha H, de Vries EGE, Schröder CP, van der Vegt B. Breast Cancer Res Treat; 2023 Feb 17; 198(1):11-22. PubMed ID: 36622544 [Abstract] [Full Text] [Related] Page: [Next] [New Search]